Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

Comparative Evaluation of Custom Convolutional Neural Networks and EfficientNet-B3 for Malaria Cell Image Classification: Impact of Targeted Data Augmentation on Model Performance

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F25%3A10506820" target="_blank" >RIV/00216208:11110/25:10506820 - isvavai.cz</a>

  • Výsledek na webu

    <a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=TQi6mnB7yC" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=TQi6mnB7yC</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.61882/ijbc.17.3.62" target="_blank" >10.61882/ijbc.17.3.62</a>

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    Comparative Evaluation of Custom Convolutional Neural Networks and EfficientNet-B3 for Malaria Cell Image Classification: Impact of Targeted Data Augmentation on Model Performance

  • Popis výsledku v původním jazyce

    Background: Malaria diagnosis with thin blood smears remains labor-intensive and relies on the operator. Deep learning could enable accurate automation. Objective: Compare four convolutional approaches for classifying parasitized versus uninfected erythrocytes and to evaluate whether targeted image-quality augmentations enhance performance. Materials and Methods: We used the balanced NIH/Kaggle dataset, which included 13,780 parasitized and 13,780 uninfected samples. Data were split stratified into training, validation, and test sets (70/15/15). Images were resized to 256x256 and normalized. Four experiments were conducted: (1) a custom CNN; (2) the same CNN with targeted augmentation applied to 20% of training samples per class-using Contrast Limited Adaptive Histogram Equalization [CLAHE] and controlled brightness adjustment-and augmented images were added back to the training set (totaling 30,864 images); (3) a soft-attention parallel CNN (SPCNN); and (4) transfer learning with EfficientNet-B3 on 300x300 inputs with full fine-tuning. Evaluation metrics included accuracy, precision, recall, F1 score, and AUC-ROC. Results: EfficientNet-B3 achieved the highest performance with a validation accuracy of 0.9741, 98% precision, 96% recall, an F1 score of 0.97, and an AUC-ROC of 0.9964. SPCNN was competitive but slightly lower, with a validation accuracy of 0.9652, 98% precision, 95% recall, an F1 score of 0.96, and an AUC-ROC of 0.9909. The baseline CNN had a validation accuracy of 0.9649, 97% precision, 94% recall, an F1 score of 0.96, and an AUC-ROC of 0.9910. Targeted augmentation resulted in negligible change compared to the baseline CNN, with a validation accuracy of 0.9647, an F1 score of 0.96, and an AUC-ROC of 0.9908, indicating limited added discriminative value for this dataset. Conclusion: EfficientNet-B3 outperformed SPCNN and custom CNNs. The CLAHE/brightness strategy applied to 20% of training images and added back to the dataset did not significantly improve generalization. External validation and prospective field testing are necessary before clinical deployment.

  • Název v anglickém jazyce

    Comparative Evaluation of Custom Convolutional Neural Networks and EfficientNet-B3 for Malaria Cell Image Classification: Impact of Targeted Data Augmentation on Model Performance

  • Popis výsledku anglicky

    Background: Malaria diagnosis with thin blood smears remains labor-intensive and relies on the operator. Deep learning could enable accurate automation. Objective: Compare four convolutional approaches for classifying parasitized versus uninfected erythrocytes and to evaluate whether targeted image-quality augmentations enhance performance. Materials and Methods: We used the balanced NIH/Kaggle dataset, which included 13,780 parasitized and 13,780 uninfected samples. Data were split stratified into training, validation, and test sets (70/15/15). Images were resized to 256x256 and normalized. Four experiments were conducted: (1) a custom CNN; (2) the same CNN with targeted augmentation applied to 20% of training samples per class-using Contrast Limited Adaptive Histogram Equalization [CLAHE] and controlled brightness adjustment-and augmented images were added back to the training set (totaling 30,864 images); (3) a soft-attention parallel CNN (SPCNN); and (4) transfer learning with EfficientNet-B3 on 300x300 inputs with full fine-tuning. Evaluation metrics included accuracy, precision, recall, F1 score, and AUC-ROC. Results: EfficientNet-B3 achieved the highest performance with a validation accuracy of 0.9741, 98% precision, 96% recall, an F1 score of 0.97, and an AUC-ROC of 0.9964. SPCNN was competitive but slightly lower, with a validation accuracy of 0.9652, 98% precision, 95% recall, an F1 score of 0.96, and an AUC-ROC of 0.9909. The baseline CNN had a validation accuracy of 0.9649, 97% precision, 94% recall, an F1 score of 0.96, and an AUC-ROC of 0.9910. Targeted augmentation resulted in negligible change compared to the baseline CNN, with a validation accuracy of 0.9647, an F1 score of 0.96, and an AUC-ROC of 0.9908, indicating limited added discriminative value for this dataset. Conclusion: EfficientNet-B3 outperformed SPCNN and custom CNNs. The CLAHE/brightness strategy applied to 20% of training images and added back to the dataset did not significantly improve generalization. External validation and prospective field testing are necessary before clinical deployment.

Klasifikace

  • Druh

    J<sub>SC</sub> - Článek v periodiku v databázi SCOPUS

  • CEP obor

  • OECD FORD obor

    30502 - Other medical science

Návaznosti výsledku

  • Projekt

  • Návaznosti

    V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Ostatní

  • Rok uplatnění

    2025

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název periodika

    Iranian Journal of Blood and Cancer

  • ISSN

    2008-4595

  • e-ISSN

    2008-4609

  • Svazek periodika

    17

  • Číslo periodika v rámci svazku

    3

  • Stát vydavatele periodika

    IR - Íránská islámská republika

  • Počet stran výsledku

    11

  • Strana od-do

    62-72

  • Kód UT WoS článku

  • EID výsledku v databázi Scopus

    2-s2.0-105021799286